Kineret Approved for Still's Disease in EU
SOBI has announced that Kineret (anakinra) has been approved by the European Commission (EC)…
View Resource
IL-6 Inhibition Most Effective in Polycyclic Systemic JIA
The German Autoinflammatory Disease (AID) registry has studied the effects of the IL-6 inhibitor…
View Resource
IL-18 Binding Protein Effective in Adult-Onset Still's Disease
Gabay and colleagues have reported the results of a novel new recombinant human IL-18…
View Resource
IL-1 and IL-6 Inhibition Preferred in Systemic JIA
Since 2000, the German Biologics register (BiKeR) has prospectively enrolled children with juvenile idiopathic…
View Resource
Q Fever – The Intersection of Rheum and ID
Today in clinic, I saw a patient with longstanding seropositive, erosive rheumatoid arthritis who…
View Resource
Biologic Use in Adult-Onset Still's Disease
Adult-onset Still’s disease (AOSD) is the adult continum of systemic-onset juvenile idiopathic arthritis (SoJIA).…
View Resource
“The Big Sick” Movie Review
It’s Monday morning and my first patient is a newly diagnosed rheumatoid. This is his…
View Resource
NLRP3 Activation in Still's Disease
Adult-onset Still disease (AOSD) is usually regarded as an autoinflammatory disease, largely because of…
View Resource
New Criteria for the Cryopyrinopathies (CAPS)
The diagnosis of periodic fevers is unified by undiagnosed but recurrent fever. Unfortunately the…
View Resource
NIH Discovers Otulipenia – New Infantile Autoinflammatory Disorder
Researchers at the National Institutes of Health, led by Dr. Dan Kastner, have led…
View Resource